Valiant Laboratories Limited (NSE:VALIANTLAB)
65.01
+0.20 (0.31%)
Jul 3, 2026, 3:28 PM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 3.53 billion as of July 2, 2026. Its market cap has decreased by -29.07% in one year.
Market Cap
3.53B
Enterprise Value
3.66B
Revenue
2.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
65.01
Market Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 3.53B, a decrease of -52.27%. That is a compound annual growth rate of -23.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 3.53B | -7.13% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Windlas Biotech | 17.77B |
| Ind-Swift Laboratories | 17.41B |
| Jagsonpal Pharmaceuticals | 15.78B |
| Sigachi Industries | 8.93B |
| Bafna Pharmaceuticals | 5.22B |
| Nectar Lifesciences | 2.25B |
| Brooks Laboratories | 2.24B |
| Alpa Laboratories | 1.45B |